The role of the CD[subscript 5]8 locus in multiple sclerosis
Name
De Jager-2009-The role of the CD58.pdf
Size
701.06 KB
Format
Adobe PDF
Checksum (MD5)
71a9a9ac6f0b6f533fbe274fbc390a12
Author(s)
De Jager, Philip L.
Baecher-Allan, Clare
Maier, Lisa M.
Arthur, Ariel T.
Ottoboni, Linda
Barcellos, Lisa F.
McCauley, Jacob L.
Sawcer, Stephen
Goris, An
Saarela, Janna
Date Issued
February 2009
Journal
Proceedings of the National Academy of Sciences of the United States of America
Publisher
National Academy of Sciences
Citation
De Jager, Philip L et al. “The role of the CD58 locus in multiple sclerosis.” Proceedings of the National Academy of Sciences 106.13 (2009): 5264-5269.
Version
Final published version
Abstract
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system associated with demyelination and axonal loss. A whole genome association scan suggested that allelic variants in the CD58 gene region, encoding the costimulatory molecule LFA-3, are associated with risk of developing MS. We now report additional genetic evidence, as well as resequencing and fine mapping of the CD58 locus in patients with MS and control subjects. These efforts identify a CD58 variant that provides further evidence of association with MS (P = 1.1 x 10(-6), OR 0.82) and the single protective effect within the CD58 locus is captured by the rs2300747(G) allele. This protective rs2300747(G) allele is associated with a dose-dependent increase in CD58 mRNA expression in lymphoblastic cell lines (P = 1.1 x 10(-10)) and in peripheral blood mononuclear cells from MS subjects (P = 0.0037). This protective effect of enhanced CD58 expression on circulating mononuclear cells in patients with MS is supported by finding that CD58 mRNA expression is higher in MS subjects during clinical remission. Functional investigations suggest a potential mechanism whereby increases in CD58 expression, mediated by the protective allele, up-regulate the expression of transcription factor FoxP3 through engagement of the CD58 receptor, CD2, leading to the enhanced function of CD4(+)CD25(high) regulatory T cells that are defective in subjects with MS.
MIT Department
Broad Institute of MIT and Harvard
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
http://dx.doi.org/10.1073/pnas.0813310106
